David J. Bearss
Vorstandsvorsitzender bei Halia Therapeutics, Inc.
Profil
David J.
Bearss is the founder of Montigen Pharmaceuticals, Inc., Biolexis Therapeutics, Inc. He currently holds positions as President, Chief Executive Officer & Director at Halia Therapeutics, Inc., Director at Canary Speech Inc, and Director at Xenter, Inc. His former positions include Chief Executive Officer & Director at Tolero Pharmaceuticals, Inc. and Chief Scientific Officer at SuperGen, Inc. He received his undergraduate degree from Brigham Young University and his doctorate from The University of Texas at Austin.
Aktive Positionen von David J. Bearss
Unternehmen | Position | Beginn |
---|---|---|
Halia Therapeutics, Inc.
Halia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Halia Therapeutics, Inc. is an American company that is discovering and developing novel therapeutics to improve the lives of patients with inflammatory disorders and neurological diseases. The company is advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses. The company is headquartered in Lehi, UT. Halia Therapeutics is discovering and developing a pipeline of novel therapeutics to improve patients' lives with chronic inflammatory disorders and neurodegenerative diseases, with its initial programs targeting LRRK2 and NLRP3. The company was founded in 2017, and the CEO is David J. Bearss. | Vorstandsvorsitzender | - |
Xenter, Inc.
Xenter, Inc. Electronic Equipment/InstrumentsElectronic Technology Xenter, Inc. is a privately held, investor-backed company that has launched a wireless techmed ecosystem designed to provide transformative outcomes for physicians, healthcare professionals, provider organizations, and patients. Xenter is headquartered in Draper, UT and was formed in 2020. The company's trademarks include xenter, xenfi, xmd, xenfi-hub, xmd, and physical intelligence. The company was founded by Richard J. Linder and he has been the CEO since incorporation. | Direktor/Vorstandsmitglied | 07.05.2021 |
Biolexis Therapeutics, Inc.
Biolexis Therapeutics, Inc. BiotechnologyHealth Technology Biolexis Therapeutics, Inc. provides potent and selective small molecule therapeutics. The company is based in Sandy, UT. The company was founded by Hariprasad Vankayalapati, David J. Bearss. | Gründer | - |
Canary Speech Inc
Canary Speech Inc Packaged SoftwareTechnology Services Canary Speech LLC engages in the development of a software that analyzes conversations using machine learning in defining neurological and cognitive diseases, ranging from Parkinson''s to dementia. The company was founded in 2016 and is headquartered in Provo, UT. | Direktor/Vorstandsmitglied | 01.01.2020 |
Ehemalige bekannte Positionen von David J. Bearss
Unternehmen | Position | Ende |
---|---|---|
Tolero Pharmaceuticals, Inc.
Tolero Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Tolero Pharmaceuticals, Inc. manufactures and markets pharmaceutical products. It is a clinical-stage biopharmaceutical company with a single-minded purpose to alleviate human suffering through the development of medicines to treat cancer and other serious human diseases. The company is headquartered in Lehi, UT. | Vorstandsvorsitzender | 30.06.2020 |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Technik-/Wissenschafts-/F&E-Leiter | 13.09.2011 |
Montigen Pharmaceuticals, Inc.
Montigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Montigen Pharmaceuticals, Inc. developed pharmaceutical products used for the treatment of cancer. Its products addressed oncology drug market with demonstrated preclinical activity in various solid tumor types, including pancreatic, colorectal, breast, prostate, and ovarian cancers. The company was founded in 2003 and was headquartered in Salt Lake City, UT. | Gründer | - |
Ausbildung von David J. Bearss
Brigham Young University | Undergraduate Degree |
The University of Texas at Austin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Health Technology |
Tolero Pharmaceuticals, Inc.
Tolero Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Tolero Pharmaceuticals, Inc. manufactures and markets pharmaceutical products. It is a clinical-stage biopharmaceutical company with a single-minded purpose to alleviate human suffering through the development of medicines to treat cancer and other serious human diseases. The company is headquartered in Lehi, UT. | Health Technology |
Montigen Pharmaceuticals, Inc.
Montigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Montigen Pharmaceuticals, Inc. developed pharmaceutical products used for the treatment of cancer. Its products addressed oncology drug market with demonstrated preclinical activity in various solid tumor types, including pancreatic, colorectal, breast, prostate, and ovarian cancers. The company was founded in 2003 and was headquartered in Salt Lake City, UT. | Health Technology |
Canary Speech Inc
Canary Speech Inc Packaged SoftwareTechnology Services Canary Speech LLC engages in the development of a software that analyzes conversations using machine learning in defining neurological and cognitive diseases, ranging from Parkinson''s to dementia. The company was founded in 2016 and is headquartered in Provo, UT. | Technology Services |
Halia Therapeutics, Inc.
Halia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Halia Therapeutics, Inc. is an American company that is discovering and developing novel therapeutics to improve the lives of patients with inflammatory disorders and neurological diseases. The company is advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses. The company is headquartered in Lehi, UT. Halia Therapeutics is discovering and developing a pipeline of novel therapeutics to improve patients' lives with chronic inflammatory disorders and neurodegenerative diseases, with its initial programs targeting LRRK2 and NLRP3. The company was founded in 2017, and the CEO is David J. Bearss. | Health Technology |
Xenter, Inc.
Xenter, Inc. Electronic Equipment/InstrumentsElectronic Technology Xenter, Inc. is a privately held, investor-backed company that has launched a wireless techmed ecosystem designed to provide transformative outcomes for physicians, healthcare professionals, provider organizations, and patients. Xenter is headquartered in Draper, UT and was formed in 2020. The company's trademarks include xenter, xenfi, xmd, xenfi-hub, xmd, and physical intelligence. The company was founded by Richard J. Linder and he has been the CEO since incorporation. | Electronic Technology |
Biolexis Therapeutics, Inc.
Biolexis Therapeutics, Inc. BiotechnologyHealth Technology Biolexis Therapeutics, Inc. provides potent and selective small molecule therapeutics. The company is based in Sandy, UT. The company was founded by Hariprasad Vankayalapati, David J. Bearss. | Health Technology |